{{Rsnum
|rsid=4776472
|Chromosome=15
|position=69714534
|Orientation=plus
|GMAF=0.3269
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.5 | 39.3 | 56.2
| HCB | 40.9 | 49.6 | 9.5
| JPT | 46.0 | 39.8 | 14.2
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 15.8 | 84.2
| CHB | 40.9 | 49.6 | 9.5
| CHD | 48.6 | 45.0 | 6.4
| GIH | 2.0 | 31.7 | 66.3
| LWK | 0.0 | 10.9 | 89.1
| MEX | 19.0 | 56.9 | 24.1
| MKK | 0.6 | 23.1 | 76.3
| TSI | 7.8 | 35.3 | 56.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs4776472
|PubMedID=17903304
|Condition=Atrial fibrillation
|Gene=KIAA1598
|Risk Allele=
|pValue=8.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs4776472
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903304; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes (Initial Sample Size: 1,341-1,345 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Atrial fibrillation.
|Drugs=
|Drug Classes=
|Diseases=Atrial Fibrillation
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356428
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4776472
|overall_frequency_n=26
|overall_frequency_d=128
|overall_frequency=0.203125
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}